Gaush Meditech Ltd

SEHK:2407 Stock Report

Market Cap: HK$1.5b

Gaush Meditech Management

Management criteria checks 3/4

Gaush Meditech's CEO is Xinwei Liu, appointed in Mar 2024, has a tenure of less than a year. total yearly compensation is CN¥1.11M, comprised of 67.6% salary and 32.4% bonuses, including company stock and options. directly owns 0.82% of the company’s shares, worth HK$12.37M. The average tenure of the management team and the board of directors is 1.7 years and 5 years respectively.

Key information

Xinwei Liu

Chief executive officer

CN¥1.1m

Total compensation

CEO salary percentage67.6%
CEO tenureless than a year
CEO ownership0.8%
Management average tenure1.7yrs
Board average tenure5yrs

Recent management updates

Recent updates

We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt

Oct 27
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt

The Consensus EPS Estimates For Gaush Meditech Ltd (HKG:2407) Just Fell A Lot

Jul 19
The Consensus EPS Estimates For Gaush Meditech Ltd (HKG:2407) Just Fell A Lot

Here's What's Concerning About Gaush Meditech's (HKG:2407) Returns On Capital

Jul 16
Here's What's Concerning About Gaush Meditech's (HKG:2407) Returns On Capital

Gaush Meditech Ltd (HKG:2407) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Jun 19
Gaush Meditech Ltd (HKG:2407) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt

Jun 03
We Think Gaush Meditech (HKG:2407) Can Stay On Top Of Its Debt

Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive

Apr 05
Revenues Working Against Gaush Meditech Ltd's (HKG:2407) Share Price Following 25% Dive

Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)

Dec 07
Estimating The Intrinsic Value Of Gaush Meditech Ltd (HKG:2407)

A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)

Aug 08
A Look At The Fair Value Of Gaush Meditech Ltd (HKG:2407)

Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry

Jun 01
Gaush Meditech Ltd's (HKG:2407) Business And Shares Still Trailing The Industry

CEO Compensation Analysis

How has Xinwei Liu's remuneration changed compared to Gaush Meditech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

CN¥91m

Mar 31 2024n/an/a

CN¥132m

Dec 31 2023CN¥1mCN¥748k

CN¥174m

Sep 30 2023n/an/a

-CN¥7m

Jun 30 2023n/an/a

-CN¥187m

Mar 31 2023n/an/a

-CN¥268m

Dec 31 2022CN¥1mCN¥726k

-CN¥350m

Sep 30 2022n/an/a

-CN¥278m

Jun 30 2022n/an/a

-CN¥207m

Mar 31 2022n/an/a

-CN¥199m

Dec 31 2021CN¥1mCN¥652k

-CN¥190m

Dec 31 2020CN¥1mCN¥641k

CN¥99m

Dec 31 2019CN¥821kCN¥632k

-CN¥37m

Compensation vs Market: Xinwei's total compensation ($USD152.75K) is below average for companies of similar size in the Hong Kong market ($USD336.37K).

Compensation vs Earnings: Xinwei's compensation has been consistent with company performance over the past year.

CEO

Xinwei Liu (42 yo)

less than a year

Tenure

CN¥1,107,000

Compensation

Mr. Xinwei Liu served as Co-Chief Executive Officer of Gaush Meditech Ltd since January 10, 2023 until March 25, 2024 and serves as Chief Executive Officer since March 25, 2024. He is Executive Director of...

Leadership Team

NamePositionTenureCompensationOwnership
Tieta Gao
Executive Chairman6.9yrsCN¥1.29m42.78%
HK$ 647.8m
Xinwei Liu
Executive Director & CEOless than a yearCN¥1.11m0.82%
HK$ 12.4m
Jianjun Zhang
Honorary President & Executive Director1.8yrsCN¥815.00kno data
Wenqi Li
CFO & Executive Director1.8yrsCN¥818.00kno data
Aleksey Nikolaevich Simonov
Chief Technology Officer1.7yrsCN¥1.96mno data
Xinli Zhao
Executive Director & Chief Compliance Officerno dataCN¥1.06mno data
Shui Bing Leung
Joint Company Secretary3yrsno datano data
Bo Zhang
Joint Company Secretaryless than a yearno datano data

1.7yrs

Average Tenure

51yo

Average Age

Experienced Management: 2407's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Tieta Gao
Executive Chairman6.9yrsCN¥1.29m42.78%
HK$ 647.8m
Xinwei Liu
Executive Director & CEO5yrsCN¥1.11m0.82%
HK$ 12.4m
Jianjun Zhang
Honorary President & Executive Director6.9yrsCN¥815.00kno data
Wenqi Li
CFO & Executive Director1.3yrsCN¥818.00kno data
Xinli Zhao
Executive Director & Chief Compliance Officer6.9yrsCN¥1.06mno data
David Wang
Non-Executive Director6.9yrsno datano data
Fan Shing Chan
Independent Non-Executive Director2yrsCN¥243.00kno data
Li-Shin Wang
Independent Non-Executive Director2yrsCN¥243.00kno data
Xin Feng
Independent Non-Executive Director2yrsCN¥243.00kno data

5.0yrs

Average Tenure

57yo

Average Age

Experienced Board: 2407's board of directors are considered experienced (5 years average tenure).